These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 19049265

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty.
    Metallidis S, Topsis D, Nikolaidis J, Alexiadou E, Lazaraki G, Grovaris L, Theodoridou A, Nikolaidis P.
    J Chemother; 2007 Dec; 19(6):682-7. PubMed ID: 18230551
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of the penetration of fluoroquinolones in human conjunctival tissue.
    Fiscella RG, Jensen MK.
    Arch Ophthalmol; 2006 Dec; 124(12):1796-7; author reply 1797. PubMed ID: 17159052
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
    Yağci R, Oflu Y, Dinçel A, Kaya E, Yağci S, Bayar B, Duman S, Bozkurt A.
    Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Collagen shields as a drug delivery system for the fourth-generation fluoroquinolones.
    Kleinmann G, Larson S, Hunter B, Stevens S, Mamalis N, Olson RJ.
    Ophthalmologica; 2007 Jul; 221(1):51-6. PubMed ID: 17183202
    [Abstract] [Full Text] [Related]

  • 30. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
    Lai WW, Chu KO, Chan KP, Choy KW, Wang CC, Tsang CW, Pang CP.
    Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model.
    Xuan D, Zhong M, Mattoes H, Bui KQ, McNabb J, Nicolau DP, Quintiliani R, Nightingale CH.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):794-9. PubMed ID: 11181363
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.
    Donnenfeld E, Perry HD, Chruscicki DA, Bitterman A, Cohn S, Solomon R.
    Curr Med Res Opin; 2004 Nov; 20(11):1753-8. PubMed ID: 15537475
    [Abstract] [Full Text] [Related]

  • 40. Aqueous penetration of gatifloxacin and levofloxacin into the rabbit aqueous humor following topical dosing.
    Levine JM, Noecker RJ, Lane LC, Snyder RW, Rapedius M, Blanchard J.
    J Ocul Pharmacol Ther; 2004 Jun; 20(3):210-6. PubMed ID: 15279726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.